These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38071136)

  • 1. Immunosurveillance associated with upper respiratory symptoms in elite swimmers: The 8-month period leading into Commonwealth Games.
    Baker LH; Desai T; Green M; Wells AV
    J Sci Med Sport; 2024 Mar; 27(3):143-148. PubMed ID: 38071136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus reactivation and upper-respiratory illness in elite swimmers.
    Gleeson M; Pyne DB; Austin JP; Lynn Francis J; Clancy RL; McDonald WA; Fricker PA
    Med Sci Sports Exerc; 2002 Mar; 34(3):411-7. PubMed ID: 11880803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valtrex therapy for Epstein-Barr virus reactivation and upper respiratory symptoms in elite runners.
    Cox AJ; Gleeson M; Pyne DB; Saunders PU; Clancy RL; Fricker PA
    Med Sci Sports Exerc; 2004 Jul; 36(7):1104-10. PubMed ID: 15235312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal immunity, respiratory illness, and competitive performance in elite swimmers.
    Pyne DB; McDonald WA; Gleeson M; Flanagan A; Clancy RL; Fricker PA
    Med Sci Sports Exerc; 2001 Mar; 33(3):348-53. PubMed ID: 11252057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of a 4-Week, Intensified Training, and Competition Period on Salivary Hormones, Immunoglobulin A, Illness Symptoms, and Mood State in Elite Synchronised Swimmers.
    Tanner A; Day S
    Sports (Basel); 2017 Sep; 5(3):. PubMed ID: 29910424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary IgA subclasses and infection risk in elite swimmers.
    Gleeson M; Hall ST; McDonald WA; Flanagan AJ; Clancy RL
    Immunol Cell Biol; 1999 Aug; 77(4):351-5. PubMed ID: 10457203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in natural killer cell subpopulations over a winter training season in elite swimmers.
    Rama L; Teixeira AM; Matos A; Borges G; Henriques A; Gleeson M; Pedreiro S; Filaire E; Alves F; Paiva A
    Eur J Appl Physiol; 2013 Apr; 113(4):859-68. PubMed ID: 22990626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary IgA levels and infection risk in elite swimmers.
    Gleeson M; McDonald WA; Pyne DB; Cripps AW; Francis JL; Fricker PA; Clancy RL
    Med Sci Sports Exerc; 1999 Jan; 31(1):67-73. PubMed ID: 9927012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune status and respiratory illness for elite swimmers during a 12-week training cycle.
    Gleeson M; McDonald WA; Pyne DB; Clancy RL; Cripps AW; Francis JL; Fricker PA
    Int J Sports Med; 2000 May; 21(4):302-7. PubMed ID: 10853703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 24-week prebiotic intervention on self-reported upper respiratory symptoms, gastrointestinal symptoms, and markers of immunity in elite rugby union players.
    Parker C; Hunter KA; Johnson MA; Sharpe GR; Gibson GR; Walton GE; Poveda C; Cousins B; Williams NC
    Eur J Sport Sci; 2023 Nov; 23(11):2232-2239. PubMed ID: 37331347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal observation of Epstein-Barr virus antibodies in athletes during a competitive season.
    Pottgiesser T; Schumacher YO; Wolfarth B; Schmidt-Trucksäss A; Bauer G
    J Med Virol; 2012 Sep; 84(9):1415-22. PubMed ID: 22825820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr Virus (EBV) DNA as a Potential Marker of
    Perkins E; Davison G
    Res Q Exerc Sport; 2022 Dec; 93(4):861-868. PubMed ID: 34806947
    [No Abstract]   [Full Text] [Related]  

  • 13. Nasal symptoms, epithelial injury and neurogenic inflammation in elite swimmers.
    Steelant B; Hox V; Van Gerven L; Dilissen E; Dekimpe E; Kasran A; Aertgeerts S; Van Belle V; Peers K; Dupont LJ; Hellings PW; Bullens DM; Seys SF
    Rhinology; 2018 Sep; 56(3):279-287. PubMed ID: 29561921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Training-related risk of common illnesses in elite swimmers over a 4-yr period.
    Hellard P; Avalos M; Guimaraes F; Toussaint JF; Pyne DB
    Med Sci Sports Exerc; 2015 Apr; 47(4):698-707. PubMed ID: 25100341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intensive exercise training on immunity in athletes.
    Pyne DB; Gleeson M
    Int J Sports Med; 1998 Jul; 19 Suppl 3():S183-91; discussion S191-4. PubMed ID: 9722284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Training Regimes and Recovery Monitoring Practices of Elite British Swimmers.
    Pollock S; Gaoua N; Johnston MJ; Cooke K; Girard O; Mileva KN
    J Sports Sci Med; 2019 Sep; 18(3):577-585. PubMed ID: 31427881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation of salivary immunoglobulins in exercising and sedentary populations.
    Francis JL; Gleeson M; Pyne DB; Callister R; Clancy RL
    Med Sci Sports Exerc; 2005 Apr; 37(4):571-8. PubMed ID: 15809554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Airway hyperresponsiveness and airway inflammation in elite swimmers.
    Clin Respir J; 2009 Jan; 3(1):62. PubMed ID: 20298376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between training load and pain, injury and illness in competitive swimming: A systematic review.
    Barry L; Lyons M; McCreesh K; Powell C; Comyns T
    Phys Ther Sport; 2021 Mar; 48():154-168. PubMed ID: 33486408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of chronic training on heart rate variability, salivary IgA and salivary alpha-amylase in elite swimmers with a disability.
    Edmonds R; Burkett B; Leicht A; McKean M
    PLoS One; 2015; 10(6):e0127749. PubMed ID: 26043224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.